These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 906408)

  • 21. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes.
    Simes RJ; Kearney R; Nelson DS
    Immunology; 1975 Aug; 29(2):343-51. PubMed ID: 1158388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ; Davis RC; Parker GA; Mannick JA
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ultrastructure of experimental virus-induced hemangiopericytomas].
    Kolomiets OL
    Arkh Patol; 1975; 37(8):53-60. PubMed ID: 170893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM; Botsmanov KV
    Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.
    Forni G; Giovarelli M
    J Immunol; 1984 Jan; 132(1):527-33. PubMed ID: 6228583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR; Levy NL
    Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic and in situ natural killer activity in C57BL/6N and CBA/N mice bearing murine sarcoma virus-induced regressor tumors.
    Gerson JM; Holden HT; Herberman RB
    J Natl Cancer Inst; 1980 Nov; 65(5):905-7. PubMed ID: 6253708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the activity of oxidative enzymes in thymus cells of CBA mice during carcinogenesis induced by simian adenovirus SA7(C8)].
    Ageenko AI; Avtandilov GG; Kruglova IS; Sviridova IK
    Biull Eksp Biol Med; 1981 Jul; 92(7):80-2. PubMed ID: 6895336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
    Mizushima Y; Sendo F; Miyake T; Kobayashi H
    J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of hematopoietic system reactions of newborn and adult mice to the growth of syngeneic hepatoma H-2-73].
    Chertkova AI; Belianchikova NI; Bukhman VM
    Biull Eksp Biol Med; 1982 Jun; 93(6):90-2. PubMed ID: 7115945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.